Cancer & Devices: OncoSil Medical Ltd won US FDA Humanitarian Device Exemption approval for its OncoSil targeted radiation device for unresectable, non-metastatic distal cholangiocarcinoma, opening a projected A$80m annual US market and marking a major regulatory milestone. AI Drug Development: Cambridge is launching a £20m AI-and-human-tissue research hub at the Cambridge Stem Cell Institute to speed translation of lab findings into treatments and reduce reliance on animal research. Diabetes Wound Care: South Korean researchers unveiled a smart microneedle patch that adapts as wounds heal, helps prevent infection, and supports faster blood-vessel growth in diabetic wound models. Public Health Crisis: DR Congo’s Ebola outbreak has become the deadliest in history, with 2,325 deaths and 4,945 confirmed cases as mortality rises amid surveillance and care gaps. Healthcare Access (India): West Bengal will expand Ayushman Bharat plus the state’s CM health scheme to cover 1,850 hospitals, including cashless care beyond state borders. Safety & Regulation: Kenya’s Pharmacy and Poisons Board urged consumers to spot suspected fake medicines via packaging and appearance checks, warning of ongoing safety alerts. Local Care & Infrastructure: Armenia allocated 1.444bn drams for renovation and new equipment at its National Center for Nuclear Medicine, including modern PET/CT and imaging systems. Community Health: A family-owned LGBTQ-support pharmacy in Woodland was vandalized in a suspected hate crime, with owners calling for protection and accountability.